BlackRock Fund Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $128M | Buy |
7,891,641
+838,740
| +12% | +$13.6M | 0.02% | 1013 |
|
|
2016
Q3 | $128M | Buy |
7,052,901
+374,765
| +6% | +$6.79M | 0.03% | 893 |
|
|
2016
Q2 | $110M | Buy |
6,678,136
+3,740,449
| +127% | +$61.6M | 0.02% | 898 |
|
|
2016
Q1 | $48.7M | Buy |
2,937,687
+208,391
| +8% | +$3.45M | 0.01% | 1475 |
|
|
2015
Q4 | $59.1M | Sell |
2,729,296
-310,832
| -10% | -$6.74M | 0.01% | 1363 |
|
|
2015
Q3 | $60.3M | Buy |
3,040,128
+1,010,150
| +50% | +$20M | 0.02% | 1292 |
|
|
2015
Q2 | $70.5M | Buy |
+2,029,978
| New | +$70.5M | 0.02% | 1275 |
|
|
2014
Q3 | – | Sell |
-2,303,695
| Closed | -$36.4M | – | 3908 |
|
|
2014
Q2 | $36.4M | Sell |
2,303,695
-33,043
| -1% | -$523K | 0.01% | 1617 |
|
|
2014
Q1 | $35.3M | Buy |
2,336,738
+177,664
| +8% | +$2.69M | 0.01% | 1642 |
|
|
2013
Q4 | $16.5M | Buy |
2,159,074
+699,267
| +48% | +$5.33M | 0.01% | 2097 |
|
|
2013
Q3 | $4.89M | Buy |
1,459,807
+154,431
| +12% | +$517K | ﹤0.01% | 2824 |
|
|
2013
Q2 | $3.21M | Buy |
+1,305,376
| New | +$3.21M | ﹤0.01% | 2951 |
|